menu
    • menu

    Company profile for Glox Therapeutics

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Glox Therapeutics, founded in February 2023, is the result of collaborative efforts led by Professor Daniel Walker, Professor Colin Kleanthous, and Dr. James Clark. The company aims to capitalize on recent advancements in the understanding of bacteriocin structure and mode of action, which originated from the laboratories of Professors Walker and Kleanthous at the University of Glasgow and the University of Oxford, respectivel...
    Glox Therapeutics, founded in February 2023, is the result of collaborative efforts led by Professor Daniel Walker, Professor Colin Kleanthous, and Dr. James Clark. The company aims to capitalize on recent advancements in the understanding of bacteriocin structure and mode of action, which originated from the laboratories of Professors Walker and Kleanthous at the University of Glasgow and the University of Oxford, respectively. Glox Therapeutics is backed by a network of highly experienced scientific advisers and has garnered support and investment from prominent entities such as the Boehringer Ingelheim Venture Fund and Scottish Enterprise.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Glox Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    11 The Square University Of Glasgow University Avenue Glasgow G12 8QQ
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://gloxtherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/glox-therapeutics-ltd/?originalSubdomain=uk
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Glox Adds Dr. Michael Murray As Chair, Dr. Nel To Advisory Board
    Glox Adds Dr. Michael Murray As Chair, Dr. Nel To Advisory Board

    11 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250211779468/en

    BUSINESSWIRE
    11 Feb 2025
    Share Share
    Glox Wins £3M Funding For Cystic Fibrosis Antimicrobial Research
    Glox Wins £3M Funding For Cystic Fibrosis Antimicrobial Research

    21 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250121359434/en

    BUSINESSWIRE
    21 Jan 2025
    Share Share
    Glox Therapeutics Awarded £1M Grant for Antibiotics Development
    Glox Therapeutics Awarded £1M Grant for Antibiotics Development

    20 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241119981933/en

    BUSINESSWIRE
    20 Nov 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search